ClinVar Genomic variation as it relates to human health
NM_001353921.2(ARHGEF9):c.442A>G (p.Ser148Gly)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_001353921.2(ARHGEF9):c.442A>G (p.Ser148Gly)
Variation ID: 566826 Accession: VCV000566826.8
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: Xq11.1 X: 63697265 (GRCh38) [ NCBI UCSC ] X: 62917145 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Oct 10, 2018 Feb 14, 2024 Oct 31, 2018 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_001353921.2:c.442A>G MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_001340850.1:p.Ser148Gly missense NM_001173479.2:c.262A>G NP_001166950.1:p.Ser88Gly missense NM_001173480.2:c.115A>G NP_001166951.1:p.Ser39Gly missense NM_001330495.2:c.358A>G NP_001317424.1:p.Ser120Gly missense NM_001353922.2:c.442A>G NP_001340851.1:p.Ser148Gly missense NM_001353923.1:c.460A>G NP_001340852.1:p.Ser154Gly missense NM_001353924.2:c.241A>G NP_001340853.1:p.Ser81Gly missense NM_001353926.2:c.241A>G NP_001340855.1:p.Ser81Gly missense NM_001353927.2:c.358A>G NP_001340856.1:p.Ser120Gly missense NM_001353928.2:c.421A>G NP_001340857.1:p.Ser141Gly missense NM_001369030.1:c.421A>G NP_001355959.1:p.Ser141Gly missense NM_001369031.1:c.421A>G NP_001355960.1:p.Ser141Gly missense NM_001369032.1:c.421A>G NP_001355961.1:p.Ser141Gly missense NM_001369033.1:c.358A>G NP_001355962.1:p.Ser120Gly missense NM_001369034.1:c.358A>G NP_001355963.1:p.Ser120Gly missense NM_001369035.1:c.358A>G NP_001355964.1:p.Ser120Gly missense NM_001369036.1:c.358A>G NP_001355965.1:p.Ser120Gly missense NM_001369037.1:c.358A>G NP_001355966.1:p.Ser120Gly missense NM_001369038.1:c.358A>G NP_001355967.1:p.Ser120Gly missense NM_001369039.1:c.241A>G NP_001355968.1:p.Ser81Gly missense NM_001369040.1:c.241A>G NP_001355969.1:p.Ser81Gly missense NM_001369041.1:c.358A>G NP_001355970.1:p.Ser120Gly missense NM_001369042.1:c.115A>G NP_001355971.1:p.Ser39Gly missense NM_001369043.1:c.358A>G NP_001355972.1:p.Ser120Gly missense NM_001369044.1:c.358A>G NP_001355973.1:p.Ser120Gly missense NM_001369045.1:c.7A>G NP_001355974.1:p.Ser3Gly missense NM_015185.3:c.421A>G NP_056000.1:p.Ser141Gly missense NC_000023.11:g.63697265T>C NC_000023.10:g.62917145T>C NG_016975.1:g.93282A>G - Protein change
- S141G, S148G, S120G, S39G, S3G, S81G, S88G, S154G
- Other names
- -
- Canonical SPDI
- NC_000023.11:63697264:T:C
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
The Genome Aggregation Database (gnomAD) 0.00001
Trans-Omics for Precision Medicine (TOPMed) 0.00001
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
ARHGEF9 | Sufficient evidence for dosage pathogenicity | No evidence available |
GRCh38 GRCh37 |
445 | 578 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Uncertain significance (2) |
criteria provided, multiple submitters, no conflicts
|
Oct 31, 2018 | RCV000686743.9 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Uncertain significance
(Oct 31, 2018)
|
criteria provided, single submitter
Method: clinical testing
|
Developmental and epileptic encephalopathy, 8
Affected status: unknown
Allele origin:
unknown
|
Fulgent Genetics, Fulgent Genetics
Accession: SCV000897578.1
First in ClinVar: Mar 31, 2019 Last updated: Mar 31, 2019 |
|
|
Uncertain significance
(May 29, 2018)
|
criteria provided, single submitter
Method: clinical testing
|
Developmental and epileptic encephalopathy, 8
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV000814275.4
First in ClinVar: Oct 10, 2018 Last updated: Feb 14, 2024 |
Comment:
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant … (more)
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with ARHGEF9-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change replaces serine with glycine at codon 141 of the ARHGEF9 protein (p.Ser141Gly). The serine residue is highly conserved and there is a small physicochemical difference between serine and glycine. (less)
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpThere are no citations for germline classification of this variant in ClinVar. If you know of citations for this variation, please consider submitting that information to ClinVar. |
Text-mined citations for rs1394345886 ...
HelpRecord last updated Sep 29, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.